Last updated: June 5, 2026
Argatroban in Sodium Chloride Suppliers: Who Manufactures the Drug Product and Components?
No complete, citable dataset is available here for ARGATROBAN IN SODIUM CHLORIDE (drug product suppliers, CDMO roles, labeler/manufacturer names, and sourcing of argatroban API and sodium chloride injection components) in a way that supports a complete and accurate supplier list.
What companies supply argatroban in sodium chloride injection in the US market?
Featured snippet answer: A supplier list requires product-level sourcing data (NDC/labeler/manufacturer or FDA drug product listing) for “argatroban in sodium chloride injection.” Without that dataset, no defensible supplier identification can be produced.
Which supplier data sources normally identify product manufacturers?
- FDA Drugs@FDA labeler/manufacturer identifiers for the specific dosage form and strength
- FDA NDC Directory and establishment links
- Orange Book (if listed) for NDA-related drug product firms
- Lot-level or packaging-level disclosures from the label (carton/bottle imprint and manufacturer statements)
Which suppliers provide argatroban API for compounded or injectable products?
Featured snippet answer: API suppliers are identified via drug master files, regulatory filings, and establishment registration entries linked to the exact API. Without establishment-linked records for argatroban API, no accurate company mapping can be listed.
What API sourcing patterns exist for argatroban?
- API is typically supplied under DMF by API manufacturers
- Contract manufacture may be performed by CDMOs that package sterile drug product
- Final sterile fill-finish may be performed by a different establishment than API manufacture
Who supplies sterile fill-finish for argatroban injection in sodium chloride?
Featured snippet answer: Sterile fill-finish suppliers are establishment-level CDMOs tied to the marketed injection. Without establishment identifiers tied to the product’s NDC or labeler, no defensible supplier list can be generated.
What fill-finish information is usually needed to name CDMOs
- FDA establishment registration for the specific dosage form (sterile solution)
- Product listing that links NDC to a particular manufacturing establishment
- Contract manufacturing disclosures on labels or in regulatory submissions
How does “argatroban in sodium chloride” differ from other argatroban presentations and how does that affect suppliers?
Featured snippet answer: Suppliers change with the presentation because the drug product listing (NDC) and manufacturing establishment can differ by concentration, vial size, and diluent composition. Without the exact NDC(s) for the “in sodium chloride” product, supplier mapping cannot be completed.
Common differentiators that trigger different manufacturing and packaging
- Concentration (mg/mL), vial size, and container-closure system
- Whether sodium chloride is prefilled as the diluent versus separate vial components
- Storage and handling requirements tied to the marketed sterile solution
What is the Orange Book status of argatroban in sodium chloride and does it affect supplier selection?
Featured snippet answer: Orange Book status does not directly identify suppliers unless tied to an NDA listing and associated labeler/manufacturer entries. No authoritative Orange Book-linked supplier mapping can be produced without the specific NDA/NDC identification.
What supplier-relevant details Orange Book entries can include
- NDA holder and listed drug product firms
- Patent expiration and exclusivity that can constrain manufacturing entrants
Which generic or biosimilar competitors would change the supplier landscape?
Featured snippet answer: There is no basis to name generic entrants or competitive suppliers without identifying the specific NDA, NDC(s), and current FDA approval status for the “argatroban in sodium chloride” injection.
What usually changes supplier dynamics
- Paragraph IV or settlements can shift who manufactures the commercial product
- Switching labeler or contract manufacturer can change supply chain reliability and pricing
Key Takeaways
- A complete, accurate supplier list for ARGATROBAN IN SODIUM CHLORIDE requires product-specific regulatory identifiers (NDC/labeler/manufacturer and/or FDA establishment links).
- Without those identifiers in a citable dataset, naming API suppliers, sterile fill-finish CDMOs, or final drug product manufacturers would be incomplete and non-actionable.
FAQs
- How do I identify the manufacturer of “argatroban in sodium chloride” from an NDC?
- Does the presence of sodium chloride in the label change which manufacturing establishment is used?
- How can I find argatroban API DMF holders linked to sterile injectable products?
- What indicators show whether a CDMO performs both sterile fill-finish and labeling?
- Where do pharma procurement teams source sterile injectable fill-finish capacity for argatroban products?
References
(No sources were cited because no citable product-level regulatory or listing dataset was available in the provided information.)
